Focus On Five FTSE Stocks – RR., IOF, BCN, RENE and CMCL

  • Oct 15, 2019 BST
  • Team Kalkine
Focus On Five FTSE Stocks – RR., IOF, BCN, RENE and CMCL

Rolls-Royce Holdings Plc

Rolls-Royce Holdings Plc (RR.) is the United Kingdom based leading industrial technology and engineering company that provides power and propulsion-based products and services, primarily to the Civil Aerospace and defence sectors. The company’s civil aerospace segment operates as an engine manufacturer for large aircraft regional jets and other products in the business aviation markets. In the defence segment, the company is a leader in the provision of military aero-engine products as well as maritime systems in the naval space.

Financial Performance (Half Year results ended 30th June 2019)

On 6th August 2019, the company announced its half-year results for the period ended 30th June 2019. The company reported a 5 per cent year on year growth in the reported revenue to £7.883 billion in H1 2019 as compared to £7.487 billion in H1 2018. This was majorly driven by the ITP Aero segment, which was up 23 per cent year on year. The company’s reported operating profit in H1 2019 was at £83 million as compared to an operating loss of £747 million in H1 2018. Underlying profit before tax was up 16 per cent year on year from £81 million in H1 2018 to £94 million in H1 2019. The company reported a payment per share of GBX 4.6 in H1 2019, which was the same as that in H1 2018.

Share Performance

On 15th October 2019, at 09:39 A.M., while writing, Rolls-Royce Holdings Plc’s stock’s current market price was at GBX 742.80 per share, a decrease of 1.28 per cent or GBX 9.60 per share as compared to the previous day’s reported closing price which was at GBX 752.40 per share. At the current market price, the company’s shares were trading 4.06 per cent above the 52 week low price of GBX 713.80 per share, which the stock had hit on October 03, 2019. The company’s market capitalisation (M-Cap) was currently reported at £14.528 billion.

 

Iofina Plc

Iofina Plc (IOF) is a London based holding company, engaged in the exploration, development and production of Iodine, Iodine based chemical derivatives, produced water and natural gas by investing into Iodine extraction plants supported by its operations across Kentucky, Montana and Oklahoma across North America. The company extracts Iodine and the works on the development of various other chemical products developed from Iodine.

IOF 3rd Quarter Update

On 14th October 2019, the company announced an update regarding its activities in the 3rd Quarter ended 30th September 2019. At the level of the quarter’s iodine production at 167.3 metric tonnes, the company anticipates that it is likely to exceed the production level for the 2nd half of the year. The company also highlighted that global Iodine prices have only surged during the period due to the growing demand as well as tight supplies. The price at the end of the third quarter has been reported marginally north of US $32/KG and the expectations are that the prices will rise further in the next period. The company has also reported continued development in its new speciality chemical division.

IOF Share Performance

On 15th October 2019, at 10:00 A.M., while writing, Iofina Plc’s stock’s current market price was at GBX 24.65 per share, a decrease of 5.20 per cent or GBX 1.35 per share as compared to the previous day’s reported closing price which was at GBX 26.00 per share. At the current market price, the company’s shares were trading 25.94 per cent below the 52-week high price of GBX 33.28 per share, which the stock hit on May 13, 2019. The company’s market capitalisation (M-Cap) was currently reported at £49.88 million. The beta of the stock has been reported at 1.5815, which implies that the movement of the stock is more volatile as compared to the movement of the comparative benchmark index.

 

Bacanora Lithium Plc

Bacanora Lithium Plc (BCN), is the United Kingdom based Lithium Mineral exploration company that owns the Sonora Lithium, Sonora Pilot Plant and Magdalena Borate projects in Mexico and Zinnwald Lithium project in Germany. The company’s main focus and the flagship project is the Sonora Lithium Project, which is in the midst of being quickly commercialised. The location contains large and high-grade lithium deposit with an estimated resource life of 200 years and a capacity of producing 17500-35000 tonnes per annum worth of Lithium Carbonate, which is increasingly being used in the processing of metal oxides and also for the treatment of mood-related disorders. The Pilot Plant operations have been producing high-quality lithium products being used in the EV Industry, which is expected to grow exponentially in the future.

BCN Latest News

On 14th October 2019, the company made an announcement in which it reported that Ganfeng Lithium Co. has completed the strategic investment for the purchase of 29.99 per cent equity interest in the company and a 22.5 per cent Joint Venture direct ownership in the Sonora Lithium Project for a cash consideration of £21,963,740. The company has also highlighted that 57,600,364 new shares of the company are anticipated to be admitted for trading around 18th October 2019.

BCN Share Performance

On 15th October 2019, at 10:30 A.M., while writing, Bacanora Lithium Plc’s stock’s current market price was at GBX 37.00 per share, flat as compared to the previous day’s reported closing price. At the current market price, the company’s shares were trading 37.29 per cent below the 52-week high price of GBX 59.00 per share, which the stock hit on November 05, 2018. The company’s market capitalisation (M-Cap) was currently reported at £49.75 million.

ReNeuron Group Plc

ReNeuron Group Plc (RENE) is the United Kingdom based Healthcare company that is engaged in the research and development around Clinical Stage Stem cells. The company’s objectives are to develop treatments and therapies based on stem cells processes in the medical areas where these processes are either not fully developed or where needs are not met. The company is currently focused in the research and development around three major products which are Human retinal progenitor cells (hRPC), for the treatment of Retinitis Pigmentosa and is currently under phase II of the trial stage, CTX neural cell line, to treat Stroke Disabilities, currently under phase I of the trial stage and CTX-derived exosomes, for drug therapies, currently in the Pre-clinical stage.

RENE Financial performance (Preliminary results for the year ended 31st March 2019)

On 11th July 2019, the company announced its preliminary results for the year ended 31st March 2019. The company reported a decline in the loss for the year to £14.3 million in 2019 as compared to a loss of £17.6 million in 2018. The company’s cash outflow also reduced from £14.9 million in 2018 to £12.0 million in 2019. The loss for the period reduction was majorly driven by an increase in the financial income during the period from £300,000 to £1.1 million and not incurring the Finance expense as compared to the previous year which was reported to be at £911,000.

RENE Share Performance

On 15th October 2019, at 10:51 A.M., while writing, ReNeuron Group Plc’s stock’s current market price was at GBX 128.85 per share, a decrease of 9.58 per cent or GBX 13.66 per share as compared to the previous day’s reported closing price at GBX 142.50 per share. At the current market price, the company’s shares were trading 186.32 per cent above the 52-week low price of GBX 45.00 per share, which the stock hit on February 18, 2019. The company’s market capitalisation (M-Cap) was currently reported at £45.36 million.

Caledonia Mining Corporation Plc

Caledonia Mining Corporation Plc (CMCL) is the United Kingdom based mining company with operations focused around exploration and development of gold mines in Southern Africa, especially Zimbabwe. The company’s flagship project is the Blanket Gold Mine near the Gwanda region of Zimbabwe. The company has been involved in the production of over 1 million ounces of gold to date from the mine.

CMCL Q3 2019 Production Update

On 14th October 2019, the company announced the production update for the quarter ended 30th September 2019. The company reported production of 13,646 oz. of gold during the period, which was up 7.3 per cent year on year. The company’s year to date production was at 38,306 oz. of gold, an increase of 3.2 per cent year on year. The company also highlighted that it would maintain its production guidance expectations for the year at 50,000 to 53,000 oz. and is on track to target yearly production of 80,000 oz. per year by 2022.

CMCL Share Performance

On 15th October 2019, at 10:53 A.M. GMT, Caledonia Mining Corporation Plc’s stocks were trading at GBX 565.00 per share, unchanged as compared to the previous day’s reported closing price. As of the last trading price, the company’s shares were trading 5.60 per cent below the 52-week high price of GBX 598.50 per share, which the stock hit on September 17, 2019. The company’s market capitalisation (M-Cap) was currently reported at £60.74 million.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK